Paper17522241
Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
Kunnimalaiyaan M and 1 other. Oncologist, 2007. Cited by 166 papers, by iCite.
Cite this record
ConductScience Library. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. Papers, record 17522241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17522241
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroendocrine Tumors | Major topic |
| Receptor, Notch1 | Major topic |
| Signal Transduction | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Animals | |
| Carcinoid Tumor | |
| Carcinoma, Medullary | |
| Carcinoma, Small Cell | |
| Humans | |
| Lung Neoplasms |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA109053 | NCI NIH HHS | United States | R01CA109053 | PubMed and NIH | NIH RePORTER |
| DK064735 | NIDDK NIH HHS | United States | R21DK064735 | PubMed and NIH | NIH RePORTER |
Cited by110
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42656227 | DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42656227 | PubMed |
| 42464673 | Recent progress and therapeutic strategies in the treatment of cervical neuroendocrine neoplasms (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42464673 | PubMed |
| 42001853 | NFIB Regulates Chemoresistance in Small Cell Lung Cancer by Suppressing Notch Signaling Activity. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42001853 | PubMed |
| 41415276 | Expanding the immunotherapy universe in extensive-stage small cell lung cancer: from chemoimmunotherapy backbone to next-wave combinations. | Front Immunol | 2025 | https://conductscience.org/library/papers/41415276 | PubMed |
| 40694161 | Natural bioactive compounds as notch signaling modulators: cutting-edge strategies for cancer therapy. | Med Oncol | 2025 | https://conductscience.org/library/papers/40694161 | PubMed |
| 40627448 | NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40627448 | PubMed |
| 40595495 | Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma. | Nat Commun | 2025 | https://conductscience.org/library/papers/40595495 | PubMed |
| 40133552 | NELL2 suppresses epithelial-mesenchymal transition and induces ferroptosis via notch signaling pathway in HCC. | Sci Rep | 2025 | https://conductscience.org/library/papers/40133552 | PubMed |
| 39865119 | Exploring the expression of DLL3 in gastroenteropancreatic neuroendocrine neoplasms and its potential diagnostic value. | Sci Rep | 2025 | https://conductscience.org/library/papers/39865119 | PubMed |
| 39822777 | Everything you ever wanted to know about cancer stem cells in neuroendocrine neoplasms but were afraid to ask. | Endocr Oncol | 2024 | https://conductscience.org/library/papers/39822777 | PubMed |
| 39703856 | Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions. | Front Oncol | 2024 | https://conductscience.org/library/papers/39703856 | PubMed |
| 39392394 | Relationship between the expressions of DLL3, ASC1, TTF-1 and Ki-67: First steps of precision medicine at SCLC. | Oncotarget | 2024 | https://conductscience.org/library/papers/39392394 | PubMed |
| 39201255 | An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201255 | PubMed |
| 39125516 | NOTCH1- and CD117-Positive Stem Cells in Human Endometriosis and Adenomyosis Lesions. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39125516 | PubMed |
| 36307212 | Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma. | Cold Spring Harb Mol Case Stud | 2022 | https://conductscience.org/library/papers/36307212 | PubMed |
| 36103754 | Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC). | Transl Oncol | 2022 | https://conductscience.org/library/papers/36103754 | PubMed |
| 35408894 | Modulation of Notch Signaling Pathway by Bioactive Dietary Agents. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35408894 | PubMed |
| 35305210 | Lung Neuroendocrine Tumors: How Does Molecular Profiling Help? | Curr Oncol Rep | 2022 | https://conductscience.org/library/papers/35305210 | PubMed |
| 34674268 | In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma. | Int J Cancer | 2022 | https://conductscience.org/library/papers/34674268 | PubMed |
| 34495871 | Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma. | Aging (Albany NY) | 2021 | https://conductscience.org/library/papers/34495871 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NOTCH1 | 4851 | PubTator's text mining | https://conductscience.org/library/genes/4851 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17522241
GET https://conductscience.org/api/papers/v1/17522241/cited_by?page=2